Ricerca avanzata

Yusuf Khwaja Hamied è presidente non esecutivo di Cipla Ltd. e presidente di Cipla Medpro Pty Ltd. (una controllata di Cipla Ltd.). (una filiale di Cipla Ltd.). Ha ricevuto un dottorato dall'Università di Cambridge.

Mustafa Khwaja Hamied è nel consiglio di Cipla Ltd. (ex vicepresidente esecutivo). Si è laureato all'Università di Mumbai.

Khalid Hamied was the founder of Optimi Corp.
which was founded in 2003 where he held the titles of President & Chief Technology Officer.
He previously worked as a Lead Engineer at Motorola, Inc., a Principal Engineer at MSK2 LLC, and a Senior Staff Engineer at Motorola Labs, Inc. Dr. Hamied received a doctorate degree from Georgia Institute of Technology in 1994.

Omar Khwaja currently works at Korro Bio, Inc. (Old), as Director, The Royal College of Physicians, as Member from 1999, Spinal Muscular Atrophy Foundation, as Chief Medical Officer, The Royal College of Paediatrics & Child Health, as Member, and VectivBio Holding AG, as Chief Medical Officer from 2021.
Dr. Khwaja also formerly worked at The Children's Hospital Corp., as Director-Clinical Neurogenetics Program, F.
Hoffmann-La Roche Ltd., as Global Head-Rare Diseases from 2013 to 2019, Roche Pharma (Schweiz) AG, as Global Head-Rare Diseases from 2012 to 2019, and Voyager Therapeutics, Inc., as Chief Medical Officer, Head-Research & Development from 2019 to 2021.
Dr. Khwaja received his doctorate degree from the University of Cambridge.